Read the First Edition of The Lens, a new magazine by LSI arrow-icon

Overview

Valued at ~$234 million in 2023, the atrial septal defect (ASD) closure devices market is projected to reach ~$294 million by 2028, increasing at a CAGR of 4.6% over the 2023-2028 forecast period. This Market Snapshot is part of LSI’s Market Intelligence platform, your one-stop-shop for global medtech market sizing and analysis, procedure volume data, startup company- and deal-tracking, curated insights, and more.
Atrial septal occlusion devices, often referred to as ASD closure devices, are used to close an abnormal hole in the wall of the upper chambers of the heart. While small ASDs may close on their own, larger defects require surgical repair.
Products included within the scope of this analysis include:
Implantable atrial septal occlusion devices
This Market Snapshot is intended to provide a high-level overview of the global market for ASD closure devices, with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups

ASD Closure Devices Market Snapshot Summary

Snapshot Aspect Data and Details
Base Year for Estimate 2023
Forecast Period 2023 - 2028
Market Size in 2023 $234 million
CAGR 4.6%
Projected Market Size in 2028 $294 million

ASD Closure Devices Market Insights

The ASD closure devices market is driven by two main factors: the steady increase in the global population and improvements in closure device technology. Together, these factors result in increasing levels of utilization and increasing prices. Innovations, like the GoreⓇ Cardioform Atrial Septal Defect Occluder (C-ASDO), are expanding treatment options by offering a wider range of sizes for closing ASDs, driving higher device utilization.
Additionally, both the Gore Cardioform and Abbott Amplatzer devices are FDA-approved for closing Patent Foramen Ovale (PFO), significantly expanding the potential market for transcatheter closure devices. However, it is important to note that PFO closure procedures are not included in ASD market estimates, though they contribute to the growth of the broader device segment.

Competitive Landscape

The full Market Snapshot includes a robust analysis of the competitive landscape for the ASD closure devices market. This includes estimated market revenue and market share for key players, such as Abbott, W.L. Gore, and Occlutech.
ASD closure devices market competitor breakdown.

Select Market Events

Company Date Event Type Event
Abbott
7/2023 Product Recall Abbott recalled 672 Amplatzer™ Steerable Delivery Sheaths in a Class I recall due to an increased risk of air embolism.
Occlutech
1/2024 Regulatory Occlutech announced FDA approval of two new ASD treatment devices: the OcclutechⓇ ASD Occluder and the OcclutechⓇ Pistol Pusher.

Key Companies Covered

Abbott
atHeart Medical
Lifetech Scientific
Lepu Medical
Occlutech
W.L. Gore
Buy ASD Closure Devices Market Snapshot 2024-2028
Purchase Snapshot Demo the Full Platform

Order individually or subscribe and
get a complete intel platform.

Buy this report Subscribe to All Reports

Trusted By The Companies Pioneering What’s Next

lsi logo
Contact Customer Login

Events

Market Intelligence

Resources

Schedule an exploratory call

Request Info

17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647

714-847-3540
  • social-linkedin
  • social-instagram
  • social-twitter

© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy